Article From: "Catherine Carlock"   Read full article

On an earnings conference call last week, the CEO of the life sciences developer, Joel Marcus, said the company is plotting a five-year growth plan — and that plan shows Greater Boston “will not be as dominant in our asset base as it is today.”